VitaNova Life Sciences VNOV
OTC VNOV
$1.38 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

VitaNova Life Sciences (VNOV) Gross Margin (2017 - 2026)

VitaNova Life Sciences' (VNOV) quarterly Gross Margin came in at 14.83% in Q2 2026, down 4443.0% YoY from 0.34% in Q2 2025, and down 66.74% on a QoQ basis from 44.58% in Q1 2026.

VitaNova Life Sciences (VNOV) Gross Margin (2017 - 2026) Analysis & Trends

VitaNova Life Sciences (VNOV) has 4 years of Gross Margin data on file, last reported at 14.83% in Q2 2026.

  • Quarterly Gross Margin fell 4443.0% year-over-year to 14.83% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 30.1% (down 2909.0% YoY) and the FY2026 annual result came in at 30.1%, down 2909.0% from the prior year.
  • Gross Margin fell to 14.83% in Q2 2026, from 44.58% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 100.0% in Q1 2024 to a low of 14.83% in Q2 2026.
  • A 3-year average of 59.27% and a median of 61.23% in 2025 frame the typical range for Gross Margin.
  • Annual changes were most pronounced in 2025 — Gross Margin surged 772 bps — and 2026, when it slumped 4443 bps.
  • Tracing VNOV's Gross Margin over 3 years: stood at 53.35% in 2024, then climbed by 14 bps to 61.06% in 2025, then plunged by 76 bps to 14.83% in 2026.
  • The last three Gross Margin figures came in at 14.83% (Q2 2026), 44.58% (Q1 2026), and 61.06% (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Mckesson 101.23 Bn 96.07 Bn 3.69 Bn 3.50%
2 Cencora 61.23 Bn 58.42 Bn 3.61 Bn 4.26%
3 Cardinal Health 54.35 Bn 49.49 Bn 2.56 Bn 4.02%
4 Henry Schein 10.03 Bn 9.87 Bn 1.10 Bn 31.84%
5 Akso Health 820.26 Mn 820.04 Mn - -
6 Edap Tms 159.12 Mn 137.58 Mn 7.34 Mn 55.58%
7 Accendra Health 98.94 Mn 91.29 Mn 263.41 Mn 42.95%
8 111 30.87 Mn 109.39 Mn 18.18 Mn 5.31%
9 Cosmos Health 13.30 Mn 10.85 Mn 1.51 Mn 7.96%
10 VitaNova Life Sciences 11.51 Mn 9.91 Mn 264,662.00 14.83%

Historic Data

Download Data
DateValue
Apr 30, 2026 14.83%
Jan 31, 2026 44.58%
Oct 31, 2025 61.06%
Jul 31, 2025 66.20%
Apr 30, 2025 59.26%
Jan 31, 2025 61.40%
Oct 31, 2024 53.35%
Jul 31, 2024 67.45%
Apr 30, 2024 64.56%
Jan 31, 2024 100.00%
Jul 31, 2017 84.24%